Mevinolin enhances osteogenic genes (ALP, type I collagen and osteocalcin), CD44, CD47 and CD51 expression during osteogenic differentiation

Life Sciences

Volumn 84, Issue 9-10, 2009, Pages 290-295

  Kim, Hyung Keun ^a,b   Cho, Sang Gwon ^a   Kim, Ji Hyun ^a,b   Doan, Thi Kim Phuong ^a,b   Hu, Qin Sheng ^a,b   Ulhaq, Rehan ^a   Song, Eun Kyoo ^a   Yoon, Taek Rim ^a,b  

^a Chonnam National University Hwasun Hospital and Medical School   (South Korea)

^b Chonnam National University   (South Korea)

Author keywords

ALP; CD44; CD47; CD51; Osteocalcin; Statin; Type I collagen, Mevinolin

Indexed keywords

ALKALINE PHOSPHATASE; CD47 ANTIGEN; CD51 ANTIGEN; COLLAGEN TYPE 1; HERMES ANTIGEN; MEVINOLIN; OSTEOCALCIN;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; ENZYME ACTIVITY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; MOUSE; NONHUMAN; OSTEOBLAST; REAL TIME POLYMERASE CHAIN REACTION; STROMA CELL; X RAY SPECTROMETRY;

ALKALINE PHOSPHATASE; ANIMALS; ANTIGENS, CD44; ANTIGENS, CD47; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINE; COLLAGEN TYPE I; GENE EXPRESSION REGULATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTEGRIN ALPHAV; LOVASTATIN; MICE; MULTIPOTENT STEM CELLS; OSTEOCALCIN; OSTEOGENESIS; STROMAL CELLS;

EID: 59849113827     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.12.017     Document Type: Article

References (31)

1. Adamia S., Maxwell C.A., and Pilarski L.M. Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer. Current Drug Targets. Cardiovascular & Haematological Disorders 5 1 (2005) 3-14
2. 3. Cell 85 5 (1996) 683-693
3. Brown E.J., and Frazier W.A. Integrin-associated protein (CD47) and its ligands. Trends in Cell Biology 11 3 (2001) 130-135
4. Cabrera J.A., Bolds J., Shields P.E., Havel C.M., and Watson J.A. Isoprenoid synthesis in Halobacterium halobium. Modulation of 3-hydroxy-3-methylglutaryl coenzyme A concentration in response to mevalonate availability. Journal of Biological Chemistry 261 8 (1986) 3578-3583
5. Chen C.-H., Ho M.-L., Chang J.-K., Hung S.H., and Wang G.H. Green tea catechin enhances osteogenesis in a bone marrow mesenchymal stem cell line. Osteoporosis International 16 12 (2005) 2039-2045
6. Dahir G.A., Cui Q., Anderson P., Simon C., Joyner C., Triffitt J.T., and Balian G. Pluripotential mesenchymal cells repopulate bone marrow and retain osteogenic properties. Clinical Orthopaedics and Related Research 379 (2000) S134-S145 (supplement)
7. Dvorak M.M., Siddiqua A., Ward D.T., Carter D.H., Dallas S.L., Nemeth E.F., and Riccardi D. Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones. Proceedings of the National Academy of Sciences of the United States of America 101 14 (2004) 5140-5145
8. Felding-Habermann B., and Cheresh D.A. Vitronectin and its receptors. Current Opinion in Cell Biology 5 5 (1993) 864-868
9. Fibbe W.E. Mesenchymal stem cells. A potential source for skeletal repair. Annals of the Rheumatic Diseases 61 supplement 2 (2002) ii29-ii31
10. Ghosh-Choudhury N., Mandal C.C., and Choundhury G.G. Statin-induced ras activation integrates the phosphatidylinositol 3-kinase signal to Akt and MAPK for bone morphogenetic protein-2 expression in osteoblast differentiation. Journal of Biological Chemistry 282 7 (2007) 4983-4993
11. v integrins. In: Takada, Y., ed. Integrins: The Biological Problems. Boca Raton, Fla: CRC Press (83-99) 1994.
12. Goldstein J.L., and Brown M.S. Regulation of the mevalonate pathway. Nature 343 6257 (1990) 425-430
13. Gordon M.M., Stenenson S., and Hunter J.A. Steroids cause osteoporosis. Annals of the Rheumatic Diseases 61 10 (2002) 947-948
14. Gundberg C.M., Hauschka P.V., Lian J.B., and Gallop P.M. Osteocalcin: isolation, characterization, and detection. Methods in Enzymology 107 (1984) 516-544
15. Hughes D.E., MacDonald B.R., Russell R.G., and Gowen M. Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow. Journal of Clinical Investigation 83 6 (1989) 1930-1935
16. Julian B.A., Quarles L.D., and Niemann K.M. Musculoskeletal complications after renal transcription: pathogenesis and treatment. American Journal of Kidney Diseases 19 2 (1992) 99-120
17. Lam W.L., and Doolittle W.F. Shuttle vectors for the archaebacterium Halobacterium volcanii. Proceedings of the National Academy of Sciences of the United States of America 86 14 (1989) 5478-5482
18. Li X., Cui Q., Kao C., Wang G.J., and Balian G. Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARg2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures. Bone 33 4 (2003) 652-659
19. Li X., Jin L., Cui Q., Wang G.W., and Balian G. Steroid effects on osteogenesis through mesenchymal cell gene expression. Osteoporosis International 16 1 (2005) 101-108
20. Maeda T., Matsunuma A., Kawane T., and Horiuchi N. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. Biochemical and Biophysical Research Communications 280 3 (2001) 874-877
21. Minguell J.J., Erices A., and Conget P. Mesenchymal stem cells. Experimental Biology and Medicine (Maywood, N.J.) 226 6 (2001) 507-520
22. Motomura G., Yamamoto T., Miyanishi K., Jingushi S., and Iwamoto Y. Combined effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. Arthritis and Rheumatism 50 10 (2004) 3387-3391
23. Mundy G., Garrett R., Harris S., Chan J., Chen D., Rossini G., Boyce B., Zhao M., and Gutierrez G. Stimulation of bone formation in vitro and in rodents by statins. Science 286 5446 (1999) 1946-1949
24. Owen M.E., Cave J., and Joyner C.J. Clonal analysis in vitro of osteogenic differentiation of marrow CFU-F. Journal of Cell Science 87 5 (1987) 731-738
25. Owen T.A., Holthuis J., Markose E., van Wijnen A.J., Wolfe S.A., Grimes S.R., Lian J.B., and Stein G.S. Modifications of protein-DNA interactions in the proximal promoter of a cell-growth-regulated histone gene during onset and progression of osteoblast differentiation. Proceedings of the National Academy of Sciences of the United States of America 87 13 (1990) 5129-5133
26. Oxlund H., and Andreassen T.T. Simvastatin treatment partially prevents ovariectomy-induced bone loss while increasing cortical bone formation. Bone 34 4 (2004) 609-618
27. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., and Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284 5411 (1999) 143-147
28. Pritchett J.W. Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clinical Orthopaedics and Related Research 386 (2001) 173-178
29. Sikavitsas V.I., Temenoff J.S., and Mikos A.G. Biomaterial and bone mechanotransduction. Biomaterials 22 19 (2001) 2581-2593
30. Vinck E.M., Cagnie B.J., Cornelissen M.J., Declercq H.A., and Cambier D.C. Increased fibroblast proliferation induced by light emitting diode and low power laser irradiation. Lasers in Medical Science 18 2 (2003) 95-99
31. Vinck E.M., Cagnie B.J., Cornelissen M.J., Declercq H.A., and Cambier D.C. Green light emitting diode irradiation enhances fibroblast growth impaired by high glucose level. Photomedicine and Laser Surgery 23 2 (2005) 167-171